Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute Schizophrenia

ClinicalTrials.gov ID: NCT03160521

Public ClinicalTrials.gov record NCT03160521. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 9:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of intramuscular (IM) injections of Risperidone ISM® (75 or 100 mg) or placebo, in patients with acute exacerbation of schizophrenia.

Study identification

NCT ID
NCT03160521
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
438 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2, 2017 (Actual)
Primary completion
Dec 17, 2018 (Actual)
Completion
Dec 17, 2018 (Actual)
Last update posted
Feb 22, 2022

2017 – 2018

United States locations

U.S. sites
20
U.S. states
11
U.S. cities
20
Facility City State ZIP Site status
Woodland Research Northwest Rogers Arkansas 72758 —
CIMU Bellflower Cerritos California 90703 —
Collaborative Neuroscience Network, LLC. Garden Grove California 92845 —
Synergy Research San Diego Lemon Grove California 91945 —
Apostle Clinical Trials Long Beach California 90813 —
NRC Research Institute Orange California 92868 —
CNRI-Los Angeles LLC Pico Rivera California 90660 —
CNRI-San Diego San Diego California 92112 —
Galiz Research Hialeah Florida 33016 —
Innovative Clinical Research Inc. Hollywood Florida 33021 —
Atlanta Center for Medical Research Atlanta Georgia 30331 —
CBH Health LLC Gaithersburg Maryland 20877 —
Precise Research Centers MS Flowood Mississippi 39232 —
Altea Research Institute Las Vegas Nevada 89102 —
Hassman Research Institute Berlin New Jersey 08009 —
Midwest Clinical Research Center Dayton Ohio 45417 —
Carolina Clinical Triasl Inc Charleston South Carolina 29407 —
Community Clinical Research Inc. Austin Texas 78754 —
InSite Clinical Research DeSoto Texas 75115 —
Pillar Clinical Research LLC Richardson Texas 75080 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03160521, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2022 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03160521 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →